The crystal structure of shiga toxin type 2 with bound disaccharide guides the design of a heterobifunctional toxin inhibitor.
Jacobson, J.M., Yin, J., Kitov, P.I., Mulvey, G., Griener, T.P., James, M.N., Armstrong, G., Bundle, D.R.(2014) J Biol Chem 289: 885-894
- PubMed: 24225957 
- DOI: 10.1074/jbc.M113.518886
- Primary Citation of Related Structures:  
4M1U - PubMed Abstract: 
Shiga toxin type 2 (Stx2a) is clinically most closely associated with enterohemorrhagic E. coli O157:H7-mediated hemorrhagic colitis that sometimes progresses to hemolytic-uremic syndrome. The ability to express the toxin has been acquired by other Escherichia coli strains, and outbreaks of food poisoning have caused significant mortality rates as, for example, in the 2011 outbreak in northern Germany ...